MC1R通过代谢重编程来调节T调控细胞分化,以促进结肠癌
Shaoliang Zhu1, Mengjie Zou2, Chunxing Li3
1Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, 530021, Guangxi, China.
International immunopharmacology
|June 25, 2024
概括
在结肠癌中,梅拉诺科尔1受体 (MC1R) 的过度表达与预后不佳有关. 抑制MC1R有望通过调节T调节细胞减缓瘤生长并改善存活率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 结肠癌仍然是一个重大的全球健康挑战,晚期癌症预后不佳.
- 了解驱动结肠癌的分子机制对于开发有效治疗方法至关重要.
- 早期检测和新的治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 调查黑色皮质素1受体 (MC1R) 在结肠癌发展和进展中的作用.
- 评估MC1R表达和患者预后之间的关联.
- 阐明 MC1R 影响结肠癌的潜在分子机制.
主要方法:
- 对MC1R表达和患者预后的癌症基因组图谱 (TCGA) 数据库的分析.
- 实验模型,包括MC1R淘汰赛小鼠和体外细胞培养.
- 研究T调节细胞种群,T细胞分化和细胞代谢.
主要成果:
- 在结肠瘤组织中,MC1R过度表达,与更糟糕的预后相关.
- MC1R淘汰赛小鼠对瘤生长表现出抵抗力,T调节细胞分化和功能发生改变.
- MC1R通过重编程细胞代谢来调节T调节细胞分化,影响线粒体功能和有氧能力.
结论:
- 结肠癌中的MC1R过度表达与预后不佳有关,这是由于其调节T调节细胞分化.
- 抑制MC1R显示出作为减缓结肠癌进展的治疗策略的潜力.
- 向MC1R提供了一种新的方法来提高结肠癌患者的生存率.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.1K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


